Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 and ED95 of oxycodone combined with propofol for inhibiting spontaneous movement in hysteroscopic cervical dilatation
ChiCTR1800020007Phase 4Not yet recruiting
- Sponsor
- West China Second University Hospital
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of oxycodone and propofol in intrauterine space-occupying lesion (IUSOL) (5 arms), sponsored by West China Second University Hospital. Primary endpoint: spontaneous movement. Planned start Dec 2018; status: not yet recruiting.
02
Drugs
oxycodonepropofol
03
Conditions
intrauterine space-occupying lesion (IUSOL)
Beyond the preview
Go deeper on ChiCTR1800020007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800020007.